Cargando…

The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism

Detalles Bibliográficos
Autores principales:	Liu, Xinyu, Zhao, Xin, Na, Rui, Li, Lili, Warkentin, Eberhard, Witt, Jennifer, Lu, Xu, Yu, Yongxin, Wei, Yuquan, Peng, Guohong, Li, Yuhua, Wang, Junzhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2018
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340892/ https://www.ncbi.nlm.nih.gov/pubmed/29752689 http://dx.doi.org/10.1007/s13238-018-0551-6

Ejemplares similares

Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14
por: Huang, Rong, et al.
Publicado: (2019)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
por: Yang, Jian, et al.
Publicado: (2017)

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults
por: Khan, Siraj Ahmed, et al.
Publicado: (2016)

Development and characterization of the replicon system of Japanese encephalitis live vaccine virus SA14-14-2
por: Li, Shi-Hua, et al.
Publicado: (2013)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

Characteristics of Chimeric West Nile Virus Based on the Japanese Encephalitis Virus SA14-14-2 Backbone
por: Li, Guohua, et al.
Publicado: (2021)

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
por: Kwon, Hyo Jin, et al.
Publicado: (2015)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area
por: Turtle, Lance, et al.
Publicado: (2017)

The Infection of the Japanese Encephalitis Virus SA14-14-2 Strain Induces Lethal Peripheral Inflammatory Responses in IFNAR Deficiency Mice
por: Liu, Juan, et al.
Publicado: (2022)

Immune responses and protective effects against Japanese encephalitis induced by a DNA vaccine encoding the prM/E proteins of the attenuated SA14-14-2 strain
por: Zheng, Xiaoyan, et al.
Publicado: (2020)

T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine
por: Wang, Ran, et al.
Publicado: (2020)

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
por: Kim, Dong Soo, et al.
Publicado: (2014)

A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
por: Yun, Sang-Im, et al.
Publicado: (2014)

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines
por: Li, Yuhua, et al.
Publicado: (2017)

Correction: A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA(14)-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice
Publicado: (2014)

Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain
por: Sarkar, Arindam, et al.
Publicado: (2013)

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
por: Zaman, K., et al.
Publicado: (2022)

Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
por: Capeding, Maria Rosario, et al.
Publicado: (2020)

Importance of 14-3-3eta, anti-CarP, and anti-Sa in the diagnosis of seronegative rheumatoid arthritis
por: SALMAN, Emrah, et al.
Publicado: (2019)

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

SA14 Clinical Evidence on Corticosteroid Treatment Reported in the First Year of the COVID-19 Pandemic – Comparison of Clinical Trial Publications and Treatment Recommendation
por: Wüstner, S, et al.
Publicado: (2022)

Structurer sa pensée, structurer sa phrase : techniques d'expression orale et écrite, formation continue niveau supérieur /
por: Niquet, Gilberte
Publicado: (1987)

Développer sa créativité
por: Duhoux, Patrick, et al.
Publicado: (2006)

Danser sa vie
por: Garaudy, Roger
Publicado: (1973)

The Practice of SA-SD
por: Fisher, S
Publicado: (1989)

The practice of SA-SD
por: Fisher, S
Publicado: (1989)

Fluidra SA, Spain
Publicado: (2020)

Fluidra SA, Spain
Publicado: (2020)

Fluidra SA, Spain
Publicado: (2020)

Isolation and Genome Characterization of the Virulent Staphylococcus aureus Bacteriophage SA97
por: Chang, Yoonjee, et al.
Publicado: (2015)

Biophysicochemical characterization of Pyocin SA189 produced by Pseudomonas aeruginosa SA189
por: Naz, Sehar Afshan, et al.
Publicado: (2015)

Murine monoclonal antibody which can distinguish cystatins SA1 and SA2
por: Ito, Taichi, et al.
Publicado: (2005)

Menem-Bolocco, S.A. /
por: Wornat, Olga
Publicado: (2001)

Sartre dans sa vie
por: Jeanson, Francis, 1922-2009
Publicado: (1974)

Société nouvelle, sa nécessité.
por: Colins, Jean Guillaume César Alexandre Hippolyte, baron de, 1783-1859. [from old catalog]
Publicado: (1857)

Superheroes Against Superbugs (SaS)
Publicado: (2020)

Low temperature, mechanical wound, and exogenous salicylic acid (SA) can stimulate the SA signaling molecule as well as its downstream pathway and the formation of fruiting bodies in Flammulina filiformis
por: Li, Ziyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k5t08cvv8m475h11tc7g0qtl3c